ZGNXZOGENIX, INC.

Nasdaq www.zogenix.com


$ 26.67 $ 0.42 (1.6 %)    

Friday, 04-Mar-2022 15:59:58 EST
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 26.68
$ 26.52 x 100
$ 26.67 x 100
-- - --
$ 11.03 - $ 26.90
11,252,392
na
1.49B
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-01-2022 12-31-2021 10-K
2 11-06-2021 09-30-2021 10-Q
3 08-05-2021 06-30-2021 10-Q
4 05-06-2021 03-31-2021 10-Q
5 03-01-2021 12-31-2020 10-K
6 11-09-2020 09-30-2020 10-Q
7 08-06-2020 06-30-2020 10-Q
8 05-06-2020 03-31-2020 10-Q
9 03-02-2020 12-31-2019 10-K
10 11-07-2019 09-30-2019 10-Q
11 08-06-2019 06-30-2019 10-Q
12 05-09-2019 03-31-2019 10-Q
13 02-28-2019 12-31-2018 10-K
14 11-08-2018 09-30-2018 10-Q
15 08-06-2018 06-30-2018 10-Q
16 05-09-2018 03-31-2018 10-Q
17 03-06-2018 12-31-2017 10-K
18 11-07-2017 09-30-2017 10-Q
19 08-08-2017 06-30-2017 10-Q
20 05-04-2017 03-31-2017 10-Q
21 03-10-2017 12-31-2016 10-K
22 11-08-2016 09-30-2016 10-Q
23 08-09-2016 06-30-2016 10-Q
24 05-10-2016 03-31-2016 10-Q
25 03-15-2016 12-31-2015 10-K
26 11-09-2015 09-30-2015 10-Q
27 08-10-2015 06-30-2015 10-Q
28 05-11-2015 03-31-2015 10-Q
29 03-11-2015 12-31-2014 10-K
30 11-06-2014 09-30-2014 10-Q
31 08-06-2014 06-30-2014 10-Q
32 05-08-2014 03-31-2014 10-Q
33 03-07-2014 12-31-2013 10-K
34 11-04-2013 09-30-2013 10-Q
35 08-08-2013 06-30-2013 10-Q
36 05-09-2013 03-31-2013 10-Q
37 03-15-2013 12-31-2012 10-K
38 11-08-2012 09-30-2012 10-Q
39 08-09-2012 06-30-2012 10-Q
40 05-15-2012 03-31-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-daily-biotech-pulse-mei-pharma-wilts-on-adverse-regulatory-development-decision-day-for-zogenix-an2-therapeutics-ipo

Here's a roundup of top developments in the biotech space over the last 24 hours.

Core News & Articles

Today's 5 Stock Ideas: Boeing (BA) - Shares were down 6% Monday morning following the crash of a China Eastern Airline...

 the-week-ahead-in-biotech-march-20-26-focus-on-zogenix-fda-decision-dermatology-conference-presentations--earnings

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple confere...

 merger-arbitrage-mondays---healthcare-trust-of-america-to-combine-with-healthcare-realty-trust

Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced ...

 zogenix-to-present-new-long-term-data-on-fintepla-fenfluramine-in-lennox-gastaut-syndrome-lgs-at-aan-2022-from-april-2-7

Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, announced that...

 attention-biotech-investors-mark-your-calendar-for-march-pdufa-dates

The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded ...

 recap-zogenix-q4-earnings
Recap: Zogenix Q4 Earnings
02/28/2022 15:42:01

  Zogenix (NASDAQ:ZGNX) reported its Q4 earnings results on Monday, February 28, 2022 at 08:00 AM. Here's what investors ...

 zogenix-q4-eps-098-up-from-126-yoy-sales-2660m-up-from-850m-yoy

Zogenix (NASDAQ:ZGNX) reported quarterly losses of $(0.98) per share. This is a 22.22 percent increase over losses of $(1.26) p...

 zogenix-supports-new-no-cost-genetic-testing-program-with-united-mitochondrial-disease-foundation-to-improve-diagnosis-of-mitochondrial-diseases

Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing rare disease therapies, today announced that the company i...

 the-week-ahead-in-biotech-jan-23-29-roche-azurity-fda-decisions-jj-vertex-earnings-samsara-vision-ipo-and-more

Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. ...

 52-biggest-movers-from-yesterday
52 Biggest Movers From Yesterday
01/20/2022 09:17:24

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it wil...

 needham-downgrades-zogenix-to-hold

Needham analyst Serge Belanger downgrades Zogenix (NASDAQ:ZGNX) from Buy to Hold.

 mid-afternoon-market-update-dow-tumbles-150-points-yumanity-therapeutics-shares-plunge

Toward the end of trading Wednesday, the Dow traded down 0.45% to 35,210.04 while the NASDAQ fell 0.28% to 14,466.47. The S&...

 mid-day-market-update-us-stocks-turn-negative-zogenix-shares-spike-higher

Midway through trading Wednesday, the Dow traded down 0.13% to 35,321.51 while the NASDAQ fell 0.53% to 14,430.41. The S&P ...

 35-stocks-moving-in-wednesdays-mid-day-session

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB f...

 mid-morning-market-update-markets-rise-bank-of-america-posts-upbeat-profit

Following the market opening Wednesday, the Dow traded up 0.12% to 35,411.14 while the NASDAQ rose 0.90% to 14,638.13. The S&am...

 why-zogenix-shares-are-soaring-today

Zogenix Inc (NASDAQ: ZGNX) is trading significantly higher Wednesday morning after the company announced it received a proposal...

 20-stocks-moving-in-wednesdays-pre-market-session

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION